Emerging Nanotechnology – Driven Methods for Solublity and Dissolution Enhancement
Year: 2025
Type: article
Abstract: The idea of nanotechnology has been a breakthrough in the field of pharmaceutical science as it has become possible to precisely control materials not exceeding the nanometer scale thereby addressing significant issues like low bioavailability and poor drug solubility. The nanocarrier based systems such as nanosponges, nanoemulsions, nanosuspensions, and nanocrystals have had a great potential in enhancing drug stability, solubility, and controlled release resulting in better therapeutic outcomes. Nanosponges are porous three dimensional polymeric pore structures that can trap hydrophilic as well as hydrophobic drugs effectively, ensuing targeted and controlled drug delivery. Submicron oil-water dispersions, known as nanoemulsions offer a high interfacial surface area which increases membrane permeability, increases drug absorption, and avoids drug degradation due to the environment. These systems may be ready by the high-energy or low-energy methodology according to the formulation needs. The dissolution and bioavailability of poorly soluble drugs are greatly enhanced by nanosuspensions, or drug nanocrystals suspended in an aqueous medium along with stabilizers, by using either top-down or bottom-up manufacturing. Nanocrystals additional improve the absorption rate of drugs by raising saturation solubility and dissolution rate and are made via precipitation, spray drying, or high-pressure homogenization. Although they have advantages, such as flexibility in formulation, increased stability, and improved patient compliance, these systems can be characterized by a number of challenges, such as the problem of stability, a high level of surfactant concentration, high costs of the equipment, and the risk of toxicity. In general, nanotechnology is an effective way to overcome solubility barrier and help to create safer, more effective, and patient friendly drug delivery systems in contemporary pharmaceutical sciences.
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,620
OpenAlex ID: W7116842922
